|
Volumn 37, Issue 1, 2012, Pages
|
Adverse events associated with switching antipsychotics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
BENZODIAZEPINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLOZAPINE;
DOPAMINE 2 RECEPTOR;
DOPAMINE 2 RECEPTOR BLOCKING AGENT;
HALOPERIDOL;
HISTAMINE H1 RECEPTOR ANTAGONIST;
MUSCARINIC M1 RECEPTOR ANTAGONIST;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
SEROTONIN 2A ANTAGONIST;
SUGAR;
ZIPRASIDONE;
AGITATION;
AKATHISIA;
ANXIETY DISORDER;
APPETITE;
BLOOD PRESSURE MONITORING;
BODY WEIGHT;
COGNITIVE DEFECT;
CONFUSION;
CONSTIPATION;
DIAPHORESIS;
DIARRHEA;
DIET;
DRUG DOSE REDUCTION;
DRUG DOSE TITRATION;
DRUG SUBSTITUTION;
DRUG TARGETING;
DRUG WITHDRAWAL;
DYSKINESIA;
DYSTONIA;
EXTRAPYRAMIDAL SYMPTOM;
FEVER;
HUMAN;
HYPERSALIVATION;
HYPERTENSION;
INCREASED APPETITE;
INSOMNIA;
LIMBIC CORTEX;
LONG TERM CARE;
LOW DRUG DOSE;
MALAISE;
MEMORY DISORDER;
MENTAL DISEASE;
NAUSEA;
NOTE;
ORTHOSTATIC HYPOTENSION;
PARKINSONISM;
PHYSICAL ACTIVITY;
PSYCHOPHARMACOTHERAPY;
PSYCHOSIS;
QUALITY OF LIFE;
RECEPTOR AFFINITY;
RESTLESSNESS;
SCHIZOPHRENIA;
SEDATION;
SIDE EFFECT;
SMOOTH MUSCLE CONTRACTION;
TACHYCARDIA;
TREATMENT RESPONSE;
TREMOR;
UPREGULATION;
URINE RETENTION;
VASCULAR SMOOTH MUSCLE;
VOMITING;
WEIGHT GAIN;
XEROSTOMIA;
|
EID: 84255168904
PISSN: 11804882
EISSN: 14882434
Source Type: Journal
DOI: 10.1503/jpn.110096 Document Type: Article |
Times cited : (10)
|
References (2)
|